Study P197
Ended Awarded Last action
- Contract number
- HHSN27200015
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,833,961
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2012138 Solicitation number
- Contract value 100% obligated
- $2,833,961.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $38,143 | |
| Funding Only Action | $47,454 | |
| Funding Only Action | $56,656 | |
| Change Order | $281,941 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $322,587 | |
| Other Administrative Action | $0 | |
| Change Order | $155,219 | |
| Other Administrative Action | $0 | |
| Change Order | $355,415 | |
| Original award | $1,576,546 |
Show all 12
About this award
This federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) is for the "SIMIAN VACCINE EVALUATION UNITS" program, which is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract, valued at $2,833,961.28, is for cGMP manufacturing, testing, and other services to support the development of vaccines and other infectious disease countermeasures. ABL, a foreign-owned, for-profit manufacturer, has significant experience supporting federal agencies like NIH and HHS on infectious disease research and product development initiatives. This contract does not have a set-aside designation. ABL has been awarded multiple IDV contracts with NIH institutes, demonstrating its broad capabilities in biopharmaceutical research and development.
Quick answers
Who was awarded contract HHSN27200015?
HHSN27200015 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 15, 2016.
How much is contract HHSN27200015 worth?
The government has obligated $2,833,961 on HHSN27200015.
Is contract HHSN27200015 an order under another contract?
Yes. HHSN27200015 is a delivery order under HHSN272201300002I, an indefinite delivery contract, on Simian Vaccine Evaluation Units 2013-2020.
Was contract HHSN27200015 competed?
The extent of competition for HHSN27200015 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award